These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6086892)

  • 21. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiologic actions of lidocaine in a canine model of chronic myocardial ischemic damage--arrhythmogenic actions of lidocaine.
    Patterson E; Gibson JK; Lucchesi BR
    J Cardiovasc Pharmacol; 1982; 4(6):925-34. PubMed ID: 6185784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pro- and antiarrhythmic effects of d-sotalol and dl-sotalol in an isolated tissue model of ischemia and reperfusion.
    Pasnani JS; Ferrier GR
    J Pharmacol Exp Ther; 1994 Oct; 271(1):184-92. PubMed ID: 7965713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of drug effects on spontaneous and induced ventricular arrhythmias in a 24-h canine infarction model.
    Gomoll AW
    Arzneimittelforschung; 1987 Jul; 37(7):787-94. PubMed ID: 3118889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidysrhythmic actions of meobentine sulfate.
    Zimmerman JM; Patterson E; Pitt B; Lucchesi B
    Am Heart J; 1984 Jun; 107(6):1117-24. PubMed ID: 6720538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protection against programmed electrical stimulation-induced ventricular tachycardia and sudden cardiac death by NE-10064, a class III antiarrhythmic drug.
    Black SC; Butterfield JL; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):810-8. PubMed ID: 7509898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of activation in ventricular arrhythmias of late myocardial infarction in dogs.
    Kaplinsky E; Ogawa S; Kmetzo J; Dreifus LS
    Eur J Cardiol; 1979 Nov; 10(5):405-14. PubMed ID: 510350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifibrillatory actions of d,l-nadolol in a conscious canine model of sudden coronary death.
    Patterson E; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(5):737-44. PubMed ID: 6195459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gap junctional uncoupling plays a trigger role in the antiarrhythmic effect of ischaemic preconditioning.
    Papp R; Gönczi M; Kovács M; Seprényi G; Végh A
    Cardiovasc Res; 2007 Jun; 74(3):396-405. PubMed ID: 17362896
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta receptor blockade potentiates the antiarrhythmic actions of d-sotalol on reentrant ventricular tachycardia in a canine model of myocardial infarction.
    Kassotis J; Sauberman RB; Cabo C; Wit AL; Coromilas J
    J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1233-44. PubMed ID: 14678141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of sotalol on heart rate variability in patients with symptomatic, complex ventricular arrhythmias].
    Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Apr; 83(4):293-8. PubMed ID: 8023542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sotalol.
    Hohnloser SH; Woosley RL
    N Engl J Med; 1994 Jul; 331(1):31-8. PubMed ID: 8202100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HBI-3000 prevents secondary sudden cardiac death.
    Lee JY; Lucchesi BR
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):453-9. PubMed ID: 23615576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent.
    Black SC; Chi LG; Mu DX; Lucchesi BR
    J Pharmacol Exp Ther; 1991 Aug; 258(2):416-23. PubMed ID: 1865349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of sotalol on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs in the late postmyocardial infarction phase.
    Cobbe SM; Hoffman E; Ritzenhoff A; Brachmann J; Kübler W; Senges J
    Circulation; 1983 Oct; 68(4):865-71. PubMed ID: 6616781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of oral sotalol in suppression of premature ventricular complexes and analysis of its beta-adrenergic blocking activity.
    Giorgi C; Nadeau R; Agha A; Primeau R; de Champlain J
    Can J Cardiol; 1990 Jun; 6(5):191-7. PubMed ID: 1696514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiologic and antiarrhythmic actions of nadolol: acute ischemia in the presence of previous myocardial infarction.
    Patterson E; Lucchesi BR
    Am Heart J; 1988 Nov; 116(5 Pt 1):1223-32. PubMed ID: 3189140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrophysiologic, antiarrhythmic and cardiovascular actions of UM301, a quaternary ammonium compound.
    Gibson JK; Patterson E; Lucchesi BR
    J Pharmacol Exp Ther; 1986 Apr; 237(1):318-25. PubMed ID: 3754279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Symposium on the management of ventricular dysrhythmias. Antifibrillatory versus antiectopic therapy.
    Anderson JL
    Am J Cardiol; 1984 Jul; 54(2):7A-13A. PubMed ID: 6147079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actions of intravenous magnesium on ventricular arrhythmias caused by acute myocardial infarction.
    Nattel S; Turmel N; Macleod R; Solymoss BC
    J Pharmacol Exp Ther; 1991 Nov; 259(2):939-46. PubMed ID: 1941638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.